نتائج البحث - David Readett

  • يعرض 1 - 3 نتائج من 3
تنقيح النتائج
  1. 1
    Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer

    Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage No... حسب Christian Manegold, Donald Gravenor, Donald Woytowitz, J. Mezger, Vera Hirsh, Gary Albert, Mohammed Al-Adhami, David Readett, Arthur Μ. Krieg, Cynthia G. Leichman

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer

    A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer حسب C. Manegold, Nico van Zandwijk, A. Szczęsna, Petr Zatloukal, Joseph S. K. Au, Maria Błasińska-Morawiec, Piotr Serwatowski, Maciej Krzakowski, Jacek Jassem, E.H. Tan, Rebecca Benner, Antonella Ingrosso, Sandra J. Meech, David Readett, N. Thatcher

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

    A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis حسب Carlton Dampier, Marilyn J. Telen, Ted Wun, R. Clark Brown, Payal Desai, Fuad El Rassi, Beng Fuh, Julie Kanter, Yves D. Pastore, Jennifer Rothman, James G. Taylor, David Readett, Krupa M. Sivamurthy, Brinda Tammara, Li‐Jung Tseng, Jay N. Lozier, Helen Thackray, John L. Magnani, Kathryn L. Hassell

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: